1 min read
SIGA Wins $15 Million Canadian Defense Contract for Oral TPOXX
The award was made on behalf of the Canadian Department of National Defence through its Strategic Medical Countermeasures Program.

Public Services and Procurement Canada awarded SIGA Technologies a $15 million contract to procure oral TPOXX through a Canadian medical countermeasures program for the Department of National Defence.
The contract covers oral TPOXX, also known as tecovirimat. The purchase is part of the Strategic Medical Countermeasures Program and is for Canada's Department of National Defence.